Sm-labeled FeO@lapatinib nanoparticles as a potential therapeutic agent for breast cancer: synthesis, quality control, and evaluation.

The present study introduces FeO-coated lapatinib-labeled Sm nanoparticles (denoted as FeO@lapatinib-Sm) as a promising avenue for advancing breast cancer treatment. The radiolabeled nanoparticles combine various attributes, offering enhanced therapeutic precision. The integration of lapatinib confers therapeutic effects and targeted delivery.